![Martin G. Friedman](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Martin G. Friedman
Director/Board Member at JDS Therapeutics LLC
Martin G. Friedman active positions
Companies | Position | Start | End |
---|---|---|---|
Pharmakon Advisors LP
![]() Pharmakon Advisors LP Investment ManagersFinance Pharmakon Advisors LP (Pharmakon Advisors) is an independent private equity/venture capital firm founded in 2009, by Pablo Gerardo Legorreta and Pedro Gonzalez de Cosio. The firm is headquartered in New York, US. | Private Equity Investor | 2010-12-31 | - |
JDS Therapeutics LLC
![]() JDS Therapeutics LLC Pharmaceuticals: MajorHealth Technology JDS Therapeutics LLC develops and commercializes healthcare products to physicians, healthcare-delivery networks, and other healthcare professionals. Its products include Relizen, Serenol, and pipeline. The firms pipeline drugs include treatment for polycystic ovary syndrome (PCOS), an oral treatment for type 2 diabetes leveraging a novel mechanism of action with established safety, and a novel insulin. The company was founded by Phillip M. Satow and Michael S. Satow in 2011 and is headquartered in Purchase, NY. | Director/Board Member | - | - |
Career history of Martin G. Friedman
Former positions of Martin G. Friedman
Companies | Position | Start | End |
---|---|---|---|
NOVARTIS AG | Corporate Officer/Principal | 2005-11-30 | 2005-11-30 |
J.P. Morgan Partners (BHCA) LP
![]() J.P. Morgan Partners (BHCA) LP Investment ManagersFinance J.P. Morgan Partners (BHCA) LP engages in venture capital, private equity and leveraged buyout business. The company was founded in 1999 and is based in New York, New York. | Corporate Officer/Principal | - | - |
Merrill Lynch, Pierce, Fenner & Smith, Inc.
![]() Merrill Lynch, Pierce, Fenner & Smith, Inc. Investment Banks/BrokersFinance Founded in 1958, Merrill Lynch Piece Fenner & Smith, Inc. is an SEC registered broker/dealer located in New York City. The firm is a subsidiary of BAC North America Holding Co. and their ultimate parent is Bank of America Corp. (NYSE BAC). | Corporate Officer/Principal | - | - |
Training of Martin G. Friedman
Columbia College (Illinois) | Undergraduate Degree |
Columbia Business School | Masters Business Admin |
Statistics
International
United States | 7 |
Switzerland | 2 |
Operational
Corporate Officer/Principal | 3 |
Private Equity Investor | 1 |
Undergraduate Degree | 1 |
Sectoral
Finance | 4 |
Health Technology | 3 |
Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
NOVARTIS AG | Health Technology |
Private companies | 4 |
---|---|
Pharmakon Advisors LP
![]() Pharmakon Advisors LP Investment ManagersFinance Pharmakon Advisors LP (Pharmakon Advisors) is an independent private equity/venture capital firm founded in 2009, by Pablo Gerardo Legorreta and Pedro Gonzalez de Cosio. The firm is headquartered in New York, US. | Finance |
Merrill Lynch, Pierce, Fenner & Smith, Inc.
![]() Merrill Lynch, Pierce, Fenner & Smith, Inc. Investment Banks/BrokersFinance Founded in 1958, Merrill Lynch Piece Fenner & Smith, Inc. is an SEC registered broker/dealer located in New York City. The firm is a subsidiary of BAC North America Holding Co. and their ultimate parent is Bank of America Corp. (NYSE BAC). | Finance |
J.P. Morgan Partners (BHCA) LP
![]() J.P. Morgan Partners (BHCA) LP Investment ManagersFinance J.P. Morgan Partners (BHCA) LP engages in venture capital, private equity and leveraged buyout business. The company was founded in 1999 and is based in New York, New York. | Finance |
JDS Therapeutics LLC
![]() JDS Therapeutics LLC Pharmaceuticals: MajorHealth Technology JDS Therapeutics LLC develops and commercializes healthcare products to physicians, healthcare-delivery networks, and other healthcare professionals. Its products include Relizen, Serenol, and pipeline. The firms pipeline drugs include treatment for polycystic ovary syndrome (PCOS), an oral treatment for type 2 diabetes leveraging a novel mechanism of action with established safety, and a novel insulin. The company was founded by Phillip M. Satow and Michael S. Satow in 2011 and is headquartered in Purchase, NY. | Health Technology |
- Stock Market
- Insiders
- Martin G. Friedman
- Experience